​

Sanofi (SNY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SNY Stock Forecast

Sanofi (SNY) stock forecast, based on 24 Wall Street analysts, predicts a 12-month average price target of $57.36, with a high of $64.00 and a low of $48.07. This represents a 13.45% increase from the last price of $50.56.

$45 $49 $53 $57 $61 $65 High: $64 Avg: $57.36 Low: $48.07 Last Closed Price: $50.56

SNY Stock Rating

Sanofi stock's rating consensus is Buy, based on 24 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (58.33%), 8 Hold (33.33%), 2 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 24 0 2 8 14 Strong Sell Sell Hold Buy Strong Buy

SNY Price Target Upside V Benchmarks

TypeNameUpside
StockSanofi13.45%
SectorHealthcare Stocks 33.91%
IndustryDrug Manufacturers - General Stocks37.84%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$62.00
Last Closing Price$50.56$50.56$50.56
Upside/Downside--22.63%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25252--9
Mar, 25151--7
Feb, 25251--8
Jan, 25251--8
Dec, 24251--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2024Luisa HectorBerenberg Bank$64.00$58.519.38%26.58%
Jul 26, 2024Jasper HellwegArgus Research$60.00$52.5414.20%18.67%
Apr 03, 2024Jasper HellwegArgus Research$55.00$48.0014.58%8.78%
Dec 21, 2022Iain SimpsonBarclays$48.07$48.17-0.21%-4.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 10, 2024Deutsche BankSellSellhold
Sep 23, 2024BarclaysOverweightOverweighthold
Sep 17, 2024CitigroupBuyBuyhold
Jul 29, 2024Deutsche BankSellSellhold
Jul 11, 2024GuggenheimBuyBuyhold
Jul 02, 2024JefferiesBuyBuyhold
Aug 18, 2022OppenheimerOutperformOutperformhold
Aug 12, 2022Deutsche BankHoldupgrade
Jun 07, 2022UBSBuyBuyhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 $9 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.81$4.97$6.69$4.31-----
Avg Forecast$2.85$3.22$4.10$4.01$3.69$4.14$4.56$4.94$5.44
High Forecast$2.99$3.37$4.44$4.16$4.07$4.49$5.06$5.49$6.05
Low Forecast$2.68$3.03$3.75$3.94$3.43$3.91$4.19$4.55$5.01
Surprise %244.21%54.35%63.17%7.48%-----

Revenue Forecast

$35B $41B $47B $53B $59B $65B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$37.37B$39.17B$45.39B$43.07B-----
Avg Forecast$44.64B$43.79B$47.74B$48.99B$45.48B$48.21B$51.82B$53.99B$56.14B
High Forecast$46.32B$45.44B$50.81B$50.55B$46.93B$50.33B$56.26B$58.61B$60.94B
Low Forecast$42.66B$41.85B$44.58B$47.09B$44.08B$46.77B$48.64B$50.68B$52.69B
Surprise %-16.30%-10.55%-4.92%-12.08%-----

Net Income Forecast

$4B $6B $7B $9B $11B $13B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.29B$6.22B$8.37B$5.40B-----
Avg Forecast$7.16B$8.09B$6.46B$7.10B$4.63B$5.20B$5.72B$6.21B$6.83B
High Forecast$7.50B$8.48B$7.75B$8.52B$5.11B$5.64B$6.36B$6.90B$7.60B
Low Forecast$6.74B$7.62B$5.16B$5.68B$4.31B$4.91B$5.27B$5.71B$6.29B
Surprise %71.79%-23.03%29.66%-23.96%-----

SNY Forecast FAQ

Is Sanofi stock a buy?

Sanofi stock has a consensus rating of Buy, based on 24 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Sanofi is a favorable investment for most analysts.

What is Sanofi's price target?

Sanofi's price target, set by 24 Wall Street analysts, averages $57.36 over the next 12 months. The price target range spans from $48.07 at the low end to $64 at the high end, suggesting a potential 13.45% change from the previous closing price of $50.56.

How does Sanofi stock forecast compare to its benchmarks?

Sanofi's stock forecast shows a 13.45% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the drug manufacturers - general stocks industry (37.84%).

What is the breakdown of analyst ratings for Sanofi over the past three months?

  • April 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Sanofi’s EPS forecast?

Sanofi's average annual EPS forecast for its fiscal year ending in December 2024 is $3.69, marking a -14.39% decrease from the reported $4.31 in 2023. Estimates for the following years are $4.14 in 2025, $4.56 in 2026, $4.94 in 2027, and $5.44 in 2028.

What is Sanofi’s revenue forecast?

Sanofi's average annual revenue forecast for its fiscal year ending in December 2024 is $45.48B, reflecting a 5.60% increase from the reported $43.07B in 2023. The forecast for 2025 is $48.21B, followed by $51.82B for 2026, $53.99B for 2027, and $56.14B for 2028.

What is Sanofi’s net income forecast?

Sanofi's net income forecast for the fiscal year ending in December 2024 stands at $4.63B, representing a -14.22% decrease from the reported $5.4B in 2023. Projections indicate $5.2B in 2025, $5.72B in 2026, $6.21B in 2027, and $6.83B in 2028.